| Evolution of a Paradigm Switch in Diagnosis and Treatment of HPV-Driven Head and Neck Cancer-Striking the Balance Between Toxicity and Cure. | Frontiers in Pharmacology | 2021 |
| Machine Learning-Guided Adjuvant Treatment of Head and Neck Cancer | JAMA Network Open | 2020 |
| Deintensification Strategies Using Proton Beam Therapy for HPV-Related Oropharyngeal Cancer | International Journal of Particle Therapy | 2021 |
| Oropharyngeal Carcinoma Treated with Surgery Alone: Outcomes and Predictors of Failure | Annals of Otology, Rhinology and Laryngology | 2021 |
| Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trial | BMC Cancer | 2020 |
| Present and Future of De-intensification Strategies in the Treatment of Oropharyngeal Carcinoma | Current Oncology Reports | 2020 |
| A systematic review on Transoral robotic surgery (TORS) for carcinoma of unknown primary origin: Has tongue base mucosectomy become indispensable? | Clinical Otolaryngology | 2020 |
| Late and Long-Term Treatment-Related Effects and Survivorship for Head and Neck Cancer Patients | Current Treatment Options in Oncology | 2020 |
| Recommendations for determining HPV status in patients with oropharyngeal cancers under TNM8 guidelines: a two-tier approach | British Journal of Cancer | 2019 |
| Patterns of care and survival impact of adjuvant chemoradiotherapy for oropharyngeal cancer with intermediate-risk features | Head and Neck | 2019 |
| Oropharyngeal Cancers in the East and the West - Implications of Aetiopathogenesis on Prognosis and Research | Clinical Oncology | 2019 |
| Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age | Oral Oncology | 2018 |
| Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS) | Oral Oncology | 2018 |
| De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma | The Cochrane Library | 2018 |
| Radiation Therapy for Oral Cavity and Oropharyngeal Cancers | Dental Clinics of North America | 2018 |
| Dynamic Imaging Grade of Swallowing Toxicity (DIGEST): Scale development and validation | Cancer | 2017 |
| Symptom burden as a driver of decisional regret in long-term oropharyngeal carcinoma survivors | Head and Neck | 2017 |
| Assessment of adjuvant therapy in resected head and neck cancer with high-risk features | Oral Oncology | 2017 |
| Intensity-modulated radiotherapy in head and neck cancer - an update for oral and maxillofacial surgeons | British Journal of Oral and Maxillofacial Surgery | 2017 |
| The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma | Cancer | 2017 |
| Predictors of distant metastasis in human papillomavirus-associated oropharyngeal cancer | Head and Neck | 2017 |
| Increase in primary surgical treatment of T1 and T2 oropharyngeal squamous cell carcinoma and rates of adverse pathologic features: National Cancer Data Base | Cancer | 2016 |
| Pretreatment predictors of adjuvant chemoradiation in patients receiving transoral robotic surgery for squamous cell carcinoma of the oropharynx: a case control study | Cancers of the Head & Neck | 2016 |
| De-intensification of adjuvant therapy in human papillomavirus-associated oropharyngeal cancer | Cancers of the Head & Neck | 2016 |
| Transoral robotic surgery: The radiation oncologist's perspective | Oral Oncology | 2016 |
| Enhancing radiosensitization in EphB4 receptor-expressing Head and Neck Squamous Cell Carcinomas | Scientific Reports | 2016 |
| Primary Surgical Management of Oropharyngeal Squamous Cell Carcinoma | Current Otorhinolaryngology Reports | 2015 |
